Research
OCT-A may be noninvasive option for detecting kidney changes
Fundus blood flow changes may help reduce the number of renal pathological biopsies to identify diabetic kidney disease.
Research
Study proposes turmeric supplements reduce AMD risk
Curcumin supplement may be associated with reduced chance for AMD development and progression.
Research
Patients with glaucoma, AMD may have increased risk for systemic conditions
Concurrent AMD and glaucoma associated with heart failure and dementia, with age and inflammation as risk factors.
Pipeline
Provectus launches VisiRose to commercialize RB-PDAT for severe infectious keratitis
New biotech company will utilize rose bengal photodynamic antimicrobial therapy for its antibacterial and vision-preserving benefits.
Products
A look at 2024 ophthalmic launches
Check out our rundown on what officially went on the market this year.
Pipeline
Viridian reports positive phase 3 data on veligrotug for chronic TED
Latest THRIVE-2 study findings detail a favorable safety profile, shorter dosing regimen, and a promising diplopia response and resolution rate.
Products
Your rundown on 2024 FDA approvals
Take a trip down memory lane for a look at this year’s latest additions to the ophthalmic space.
Pipeline
FDA clears SpliceBio's IND of gene therapy for Stargardt trial
Clearance represents a significant milestone as the first-ever IND for a protein-splicing gene therapy designed to target the genetic root cause of this disease.
Pipeline
Nona Biosciences and Kodak Sciences to advance antibody therapies for ophthalmic diseases
Kodiak to further develop retinal disease asserts via Nona’s Harbour Mice platform, designed to generate fully human monoclonal antibodies at half the size of regular IgG.
Pipeline
Sun Pharma reports positive phase 4 efficacy data on CEQUA after Restasis for DED
Latest findings among patients switching from Restasis indicate significant improvements in total corneal staining and visual acuity.
Business
Tenpoint and Visus Therapeutics merge with plans for ophthalmic therapeutic advancements
Newly-combined Tenpoint Therapeutics, Ltd includes a pipeline featuring BRIMOCHOL PF, a once-daily eye drop for presbyopia targeting an NDA filing in 2025.
Pipeline
Galimedix kicks off phase 1 study on oral therapy for ocular neurodegenerative diseases
Trial will evaluate GAL-101, an amyloid beta aggregation modulator designed to provide neuroprotection and improve visual function to dry AMD and glaucoma.
Business
Bausch + Lomb purchases Elios Vision
Acquisition includes the ELIOS procedure, an excimer laser-based and implant-free MIGS technology performed during cataract surgery for glaucoma treatment.
Research
ViaLase and Moran Eye Center launch glaucoma research partnership
Collaboration combines ViaLase’s novel femtosecond laser procedure with iPerfusion technology to better understand the IOP-lowering effect.
Research
How reliable are VR devices for visual field testing?
Self-administered virtual reality visual field testing produced reliable results with high patient acceptability.
Business
SCOPE Health and CEVR partner to develop DED and OSD tech
Collaboration will focus on establishing a new standard of care for ocular surface disease to preserve and enhance vision across the globe.
Research
ARPA-H invests in four research teams for eye transplant project
National initiative seeks to develop new technologies and therapies that function as regenerative solutions to preserve or regrow nerves from the eye and to the brain.
Research
Study proposes new severity scale for diabetic macular ischemia
Researchers developed the DMI severity scale by measuring capillary nonperfusion in OCT-A imaging.
Business
Avant Technologies and Ainnova to advance low-cost retinal camera with AI software
Newly-formed joint company will develop an exclusive retinal imaging camera to be integrated into Ainnova’s disease detection digital platform.
Research